Abstract:Objective: This study discusses the therapeutic effect of high-dose urokinase treatment for hypertension ventricular hemorrhage. Methods: A total of 60 patients with hypertension ventricular hemorrhage were randomly assigned to two groups: treatment group (n = 30)and control group (n = 30). Both groups received bilateral external ventricular drain. The treatment group was injected with 50,000 IU urokinase to the lateral ventricle every day; the total injection volume per day was 100,000 IU. The control group was injected with 20,000 IU urokinase to the lateral ventricle every day with a total injection volume per day of 40,000 IU. Lumbar puncture was performed in both groups after the later ventricular drain was removed to release cerebrospinal fluid (CSF). Head Computed tomography(CT) examination was performed regularly to observe changes in the ventricular hematoma as well as the occurrence of complications such as intracranial infection and hydrocephalus. Patient prognosis 6 weeks after surgery was compared between the two groups. Results: In the treatment group, the intraventricular hemorrhage clearance time and the number of instances of urokinase treatment were significantly less than those of the control group (P<0.05). The total urokinase dosage of the treatment group was significantly higher than that of the control group (P<0.05). With respect to post-surgery complications, in the treatment group, there were three cases of hydrocephalus and one case of intracranial infection. In the control group, there were four cases of hydrocephalus and three cases of intracranial infection. Intraventricular re-hemorrhage was not observed in either group. Intracranial infection was relieved after strengthened anti-infective therapy and continuous drainage. There was a statistically significant difference in the occurrence of complications between the treatment group and the control group (P<0.05). The rate of good prognosis in the treatment group was higher than that of the control group (P<0.05), and the inefficiency rate was lower (P<0.05). Conclusions: High-dose urokinase treatment produces a significant therapeutic effect in hypertension ventricular hemorrhage. This treatment can quickly eliminate intraventricular hemorrhage, shorten the ventricular drain tube indwelling time, decrease the occurrence of intracranial infection, and increase the likelihood of a good prognosis.

Clinical observation of pressurized thrombolytic therapy for deep vein thrombosis of lower limbs.

A clinical study of high-dose urokinase for the treatment of the patients with hypertension induced ventricular hemorrhage

Catheter Directed Thrombolysis for Treatment of Acute Deep Venous Thrombosis of the Lower Extremity of the Effect and Safety Analysis in 116 Cases

AngioJet Mechanical Thrombectomy for Lower Deep Venous Thrombosis

Safety and Efficacy of Low Dosage of Urokinase for Catheter-directed Thrombolysis of Deep Venous Thrombosis

Safety and Efficiency of Delayed Thrombolysis with Urokinase in the Treatment of Low Extremity Deep Venous Thrombosis

Clinical experience of thrombectomy and catheter-directed thrombolysis in the treatment of lower extremity deep vein thrombosis

TRANSCATHETER THROMBOLYSIS VIA THE SMALL SAPHENOUS VEIN FOR ACUTE LOWER LIMB DEEP VENOUS THROMBOSIS

Application evaluation of different approaches for catheter-directed thrombolysis in acute lower-extremity deep venous thrombosis

Analysis of Efficacy of Therapy in 165 Cases of Deep Vein Thrombosis of Lower Extremity

The etiology of hypertension in the metabolic syndrome part four: the systemic perspective--the role of the neuroendocrine and immune systems, and the challenge of integration.

A new method of monitoring catheter-directed thrombolysis for deep venous thrombosis—application of D-dimer and fibrinogen testing

Catheter-directed Thrombolysis Compared with Anticoagulation Treatment for Acute Deep Venous Thrombosis-Short and Mid-Term Result

Clinical Observation of the Efficacy of the Low Molecular Weight Heparin Combined with ShuXueTong in the Treatment of the Acute Deep Venous Thrombosis of the Lower Limbs

Comparison of clear effect and the complications, and short and mid-term effects between ultrasound-guided and non-guided catheter-directed thrombolysis in the treatment of deep venous thrombosis of lower extremity

Thrombectomy monitoring by DSA combined with thrombolytic therapy for deep venous thrombosis of lower extremities

Intra-arterial Contimuous Thrombolytic Therapy for Lower Extremity Deep Vein Thrombosis

Rapid pumping of urokinase in the catheter-directed thrombolysis for the management of acute deep vein thrombosis

Catheter-directed Thrombolysis with Endovascular Angioptasty for Acute Deep Vein Thrombosis

The Effect Observation and Nursing Experience of Anisodamine and Urokinase through Intra-femoral Arterial Infusion on Lower Extremity Vascular Disease in Diabetes

Evidence-Based Nursing Model in Interventional Thrombolysis for Acute Lower Extremity Arterial Embolism